These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 32357209)

  • 1. Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies as a Serologic Marker of Infection in Patients With Coronavirus Disease 2019.
    Rongqing Z; Li M; Song H; Chen J; Ren W; Feng Y; Gao GF; Song J; Peng Y; Su B; Guo X; Wang Y; Chen J; Li J; Sun H; Bai Z; Cao W; Zhu J; Zhang Q; Sun Y; Sun S; Mao X; Su J; Chen X; He A; Gao W; Jin R; Jiang Y; Sun L
    Clin Infect Dis; 2020 Nov; 71(16):2066-2072. PubMed ID: 32357209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA.
    Kulkarni R; Patil HP; Palkar S; Lalwani S; Mishra AC; Arankalle V
    J Virol Methods; 2021 Jan; 287():113996. PubMed ID: 33126149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
    Luchsinger LL; Ransegnola BP; Jin DK; Muecksch F; Weisblum Y; Bao W; George PJ; Rodriguez M; Tricoche N; Schmidt F; Gao C; Jawahar S; Pal M; Schnall E; Zhang H; Strauss D; Yazdanbakhsh K; Hillyer CD; Bieniasz PD; Hatziioannou T
    J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32917729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France.
    Gallais F; Velay A; Nazon C; Wendling MJ; Partisani M; Sibilia J; Candon S; Fafi-Kremer S
    Emerg Infect Dis; 2021 Jan; 27(1):113-21. PubMed ID: 33261718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef MW; Imöhl M; Kleines M
    J Virol Methods; 2021 Jan; 287():113978. PubMed ID: 32979407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
    Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies.
    Hubbard JA; Geno KA; Khan J; Szczepiorkowski ZM; de Gijsel D; Ovalle AA; AlSalman AS; Gallagher TL; Johnston AA; Tibbetts AR; Vital SE; Cervinski MA; Nerenz RD
    J Appl Lab Med; 2021 Mar; 6(2):429-440. PubMed ID: 32976593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
    Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.
    Zhao J; Yuan Q; Wang H; Liu W; Liao X; Su Y; Wang X; Yuan J; Li T; Li J; Qian S; Hong C; Wang F; Liu Y; Wang Z; He Q; Li Z; He B; Zhang T; Fu Y; Ge S; Liu L; Zhang J; Xia N; Zhang Z
    Clin Infect Dis; 2020 Nov; 71(16):2027-2034. PubMed ID: 32221519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-throughput Anti-SARS-CoV-2 IgG testing platform for COVID-19.
    Du J; Chu E; Zhang D; Lu CM; Zhang A; Sha MY
    J Virol Methods; 2021 Jan; 287():114009. PubMed ID: 33152411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.
    Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L
    Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
    Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
    Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies at Delivery in Women, Partners, and Newborns.
    Egerup P; Fich Olsen L; Christiansen AH; Westergaard D; Severinsen ER; Hviid KVR; Kolte AM; Boje AD; Bertelsen MMF; Prætorius L; Zedeler A; Nielsen JR; Bang D; Berntsen S; Ethelberg-Findsen J; Storm DM; Bello-Rodríguez J; Ingham A; Ollé-López J; Hoffmann ER; Wilken-Jensen C; Krebs L; Jørgensen FS; Westh H; Jørgensen HL; la Cour Freiesleben N; Nielsen HS
    Obstet Gynecol; 2021 Jan; 137(1):49-55. PubMed ID: 33116054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure.
    Hunter BR; Dbeibo L; Weaver CS; Beeler C; Saysana M; Zimmerman MK; Weaver L
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1441-1442. PubMed ID: 32741406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa.
    Tso FY; Lidenge SJ; Peña PB; Clegg AA; Ngowi JR; Mwaiselage J; Ngalamika O; Julius P; West JT; Wood C
    Int J Infect Dis; 2021 Jan; 102():577-583. PubMed ID: 33176202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Serologic Response of Hospitalized COVID-19 Patients Using 8 Immunoassays.
    Lee SM; Kim IS; Lim S; Lee SJ; Kim WJ; Shin KH; Moon SY; Chang CL
    J Korean Med Sci; 2021 Mar; 36(9):e64. PubMed ID: 33686810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.